source
- Takeda R&D chief Andy Plump to retire in June 2027 after 12-year tenureTakeda announced that its longstanding head of research and development, Andy Plump, will step down and retire in June 2027. Plump has been with the Japanese drugmaker for about 12 years, leading…
- Tyra Biosciences shares tumble as bladder cancer pill shows lower-than-expected complete responseTyra Biosciences presented Phase 2 SURF302 data for its investigational oral drug dabogratinib in patients with low‑grade intermediate‑risk non‑muscle invasive bladder cancer. The trial reported th…